Replies to post #401921 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I disagree. Much of what you say was known, and you have had a choice even over this last year.

As for the drug and what you say is the obvious efficacy, that has to be proven and Dr.Liau is guiding that process. I doubt they are making it take longer just to frustrate shareholders and patients, who already know better. I am sure they have been carefully advised by the regulatory agencies themselves, their expert lawyers, the doctors running the trial and their SAB. That the organization is not top heavy allows them to exist on fumes. You can see it differently, certainly. Doesn’t make it quite as you suggest just because the picture can be drawn.

I think they are doing a good job of getting a trial through that I would bet, had many of the other companies that failed had a similar task, it would be a defunct product by now, or the current shareholders would have been taken out by a hedge fund, buying the IP for scraps, and then sold to another company.

I bought it because I saw a determination which is not typical, and the wherewithal to follow through regardless of consequence, while the asset was incredibly under valued and what appears to be a very valuable long-term treatment modality that they can develop for many years to treat many things. And they are pioneers still because so many failed before them.

So I see it differently.